Voleon Capital Management LP
Position in ESPR — Esperion Therapeutics, Inc.
CIK 1479847
BERKELEY, CA
Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,548,990
-19.2% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $25,492,821 across 12 Drug Manufacturers - Specialty & Generic names. ESPR ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
486,052 | $8,413,560 | |
| 2 | VTRS |
Viatris Inc
|
289,259 | $4,593,432 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,649 | $4,144,457 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
32,806 | $2,097,943 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
204,732 | $1,621,477 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
31,138 | $1,471,893 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
132,206 | $1,322,060 | |
| 8 | ZTS |
Zoetis Inc.
|
16,400 | $1,178,504 |
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 1,548,990 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 1,916,698 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 1,154,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 207,880 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||